BCRX News and Press, BioCryst Pharmaceuticals Inc. From 05/15/24

2024-05-15 09:25:53 ET Gainers: SINTX Technologies ( SINT ) +186% . Faraday Future Intelligent Electric ( FFIE ) +82% . Edible Garden AG EDBL +82% after Q1 earnings release . AERWINS Technologies ( AWIN ) +33% . Greenwave Technology Solu...

RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) today announced that new data on oral, once-daily ORLADEYO ® (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) will be presented at the European Academy ...

RESEARCH TRIANGLE PARK, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Federal Commission for Protection against Health Risks (COFEPRIS) in Mexico has granted approval for oral, once-daily ORLADEYO ® (berotralstat) f...

RESEARCH TRIANGLE PARK, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO ® (berotralstat) demonstrating that patients with hereditary angioedema (HAE) in the Unite...

2024-05-07 06:15:31 ET Summary BioCryst reported strong earnings with top and bottom line beats. Its success reflects positive performance by its approved ORLADEYO. ORLADEYO's $1 billion peak sales potential coupled with BioCryst's <$1 billion market cap makes it a speculat...

2024-05-06 18:47:50 ET For the most part, U.S. stocks had a good Monday, with the bellwether S&P 500 index confidently marching more than 1% higher. But BioCryst Pharmaceuticals (NASDAQ: BCRX) and its investors had a really good day, as the company delivered a first quar...

2024-05-06 13:00:26 ET Image source: The Motley Fool. BioCryst Pharmaceuticals (NASDAQ: BCRX) Q1 2024 Earnings Call May 06, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings...

2024-05-06 11:42:16 ET BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2024 Earnings Call Transcript May 06, 2024, 08:30 AM ET Company Participants John Bluth - IR Jon Stonehouse - CEO Charlie Gayer - CCO Helen Thackray - Chief R&D Officer Anthony Doyle - CF...

2024-05-06 10:36:37 ET More on BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation BioCryst's Revenue Gains Offset By Rising Expenses: A Closer Look BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2023 Earnings Call Transcr...

2024-05-06 07:04:28 ET More on BioCryst Pharmaceuticals BioCryst's Revenue Gains Offset By Rising Expenses: A Closer Look BioCryst Pharmaceuticals reports Q4 results Seeking Alpha’s Quant Rating on BioCryst Pharmaceuticals Read the full article on Se...